Literature DB >> 10843756

Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes.

J Michel1, H Schwarz.   

Abstract

CD137 is a member of the tumour necrosis factor receptor family which delivers a potent co-stimulatory signal to T lymphocytes. Soluble forms of CD137 (sCD137) can be found at enhanced levels in sera of patients with rheumatoid arthritis. Here we show that expression of sCD137 lags behind that of membrane-bound CD137 (mCD137) by about 24 h. In fully activated lymphocytes, time of maximum increase and level of expression of sCD137 were at day 2 and 3, respectively. Expression of sCD137 in lymphocytes requires strong activation, and levels of sCD137 correlate negatively with lymphocyte proliferation and positively with the degree of activation-induced cell death caused by mitogen overstimulation. Since activation of lymphocytes through membrane-bound CD137 delivers a potent stimulatory signal, sCD137 may provide a negative control mechanism for immune responses. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843756     DOI: 10.1006/cyto.1999.0623

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  19 in total

1.  Tumor necrosis factor receptor subfamily 9 (Tnfrsf9) gene is expressed in distinct cell populations in mouse uterus and conceptus during implantation period of pregnancy.

Authors:  Kirsten Eckstrum; Brent M Bany
Journal:  Cell Tissue Res       Date:  2011-05-12       Impact factor: 5.249

2.  Increased Peripheral CD137 Expression in a Mouse Model of Permanent Focal Cerebral Ischemia.

Authors:  Xiao-Qing Li; Yang-Yang Wang; Ting-Ting Yang; Yi-Ning Qian; He Yin; Shan-Shan Zhong; Rong A; Yang He; Bao-Lei Xu; Guang-Zhi Liu
Journal:  Cell Mol Neurobiol       Date:  2019-02-18       Impact factor: 5.046

3.  Assessment of TCR signal strength of antigen-specific memory CD8+ T cells in human blood.

Authors:  Hanchih Wu; Ashley Witzl; Hideki Ueno
Journal:  Blood Adv       Date:  2019-07-23

4.  Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters.

Authors:  T H Tu; C-S Kim; J-H Kang; I S Nam-Goong; C W Nam; E S Kim; Y I Kim; J I Choi; T Kawada; T Goto; T Park; J H Yoon Park; M-S Choi; R Yu
Journal:  Int J Obes (Lond)       Date:  2013-11-27       Impact factor: 5.095

Review 5.  Soluble immune checkpoints in cancer: production, function and biological significance.

Authors:  Daqian Gu; Xiang Ao; Yu Yang; Zhuo Chen; Xiang Xu
Journal:  J Immunother Cancer       Date:  2018-11-27       Impact factor: 13.751

6.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

7.  The B10 Idd9.3 locus mediates accumulation of functionally superior CD137(+) regulatory T cells in the nonobese diabetic type 1 diabetes model.

Authors:  Kritika Kachapati; David E Adams; Yuehong Wu; Charles A Steward; Daniel B Rainbow; Linda S Wicker; Robert S Mittler; William M Ridgway
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

8.  Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action.

Authors:  Xiaolei Tang; David E Yocum; David Dejonghe; Kathryn Nordensson; Douglas F Lake; John Richard
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

9.  Decreased 4-1BB expression on CD4+CD25 high regulatory T cells in peripheral blood of patients with multiple sclerosis.

Authors:  G-Z Liu; A C Gomes; L-B Fang; X-G Gao; P Hjelmstrom
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

10.  Recombinant CD137-Fc, its synthesis, and applications for improving the immune system functions, such as tumor immunotherapy and to reduce the inflammation due to the novel coronavirus.

Authors:  Maryam Ajami; Mahboobeh Nazari; Habibollah Mahmoodzadeh; Seyed Mohammad Moazzeni
Journal:  J Cell Biochem       Date:  2021-05-16       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.